Welcome to Digital Health Summit

2. Digital Health Summit

30st September, 2021.

Hungary’s first Digital Health conference. Digital health conference for public and private health care, digital pharma, and manufacturers of digital medical products.

Who attends: Providers / Health Systems, Payers, Pharma, Health Tech, Platform Technology Pioneers, Big Tech, Investors

Topics: Digital Health Market, Digital Health Venture, Digital Health Startups, Digital Ecosystem, Public Health Care Digital, Novartis Digital Health Startup Competition, Digital Pharma, Roche Workshop, Digital Communication for medical doctors, Responsible Telemedicine, etc.

A jegyvásárlás díja visszaigényelhető szeptember 1-ig, ha mégse tud jönni a konferenciánkra.

Keynote speakers

Prof. Dr. Kásler Miklós, PhD

Prof. Miklós Kásler, MD, Ph.D
Minister of Human Resources

Prof. Dr. Horváth Ildikó

Prof. Ildikó Horváth, MD., Ph.D.
State Secretary for Health

Mauricio Campos Suarez

Mauricio Campos Suarez
CEE Digital Lead
Novartis AG

Alexander Klein

Alexander Klein
Group Leader Digital Health F. Hoffmann
La Roche


The 1st Digital Health Summit was February 27th, 2020. We had around 400 guests and 31 journalists attended. 

The Digital Health Summit brings together public and private health care, digital pharma, and manufacturers of digital medical products, venture capitalists ynd startups from around Hungary, to network, exchange ideas and to become more familiar with opportunities in Hungary. Our independent conference will become a significant event for many companies in the DH industry and is particularly important in Hungary given the explosion of business and entrepreneurship in the region.

Digital health is the convergence of digital technologies with health, healthcare, living, and society to enhance the efficiency of healthcare delivery and make medicines more personalized and precise. The discipline involves the use of information and communication technologies to help address the health problems and challenges faced by people under treatment. These technologies include both hardware and software solutions and services, including telemedicine, web-based analysis, email, mobile phones and applications, text messages, wearable devices, and clinic or remote monitoring sensors. Generally, digital health is concerned about the development of interconnected health systems to improve the use of computational technologies, smart devices, computational analysis techniques, and communication media to aid healthcare professionals and their clients manage illnesses and health risks, as well as promote health and wellbeing.

Digital health is a multi-disciplinary domain involving many stakeholders, including clinicians, researchers and scientists with a wide range of expertise in healthcare, engineering, social sciences, public health, health economics and data management.


INSPIRED. Our speakers are leading real business transformation, driving change across the enterprise and actioning measurable digital innovation for their businesses. Get motivated from leaders and walk away with new ideas you can implement.

CHALLENGED. Rethink your current processes and business blueprints, the event speakers will challenge your way of thinking and allow you to realise that new methods may be your best way of moving forward sitting alongside your current beliefs.

TRANSFORMED. The conference agenda and speakers are put together as such to reveal insights into how some of the biggest organisations are going about digital, from real business use cases to success stories and where the challenges may lie.


NETWORKING. It's an invaluable part of events and where real value often presents itself, meeting those who are facing the same challenges and coming together to solve similar issues. Our agendas feature numerous opportunities throughout the day to meet like minded folk from various industries and backgrounds. We have previously had extremely positive feedback from delegates who have found long lasted business relationships with those who they wouldn't normally meet from opposite industries and largely seeking out the same solutions to industry wide transformation sticking points.


Concert Hall (ground floor)

keynote: Prof. Miklós Kásler, MD, PhD, Minister of Human Resources, Hungary presentation

keynote: Pharma Ecosystem Innovation: Value proposition & real life experience - Top 3 highlights and learnings from running open innovation for pharma + to bring some insights/outside-in perspective from The Wide lens theory + Novartis BIOME CEE plans + what we could propose to start today to collaborate with Hungary Startups ecosystem - Mauricio Campos Suarez (Novartis AG) 

keynote: Alexander Klein (Group Leader Digital Health F. Hoffmann - La Roche) presentation

keynote: Abundant funding to boost research, development and innovation in HungaryIn terms of innovation performance, Hungary is a moderate innovator in the EU, but we aspire to be among the leaders by the end of the decade. According to the latest data from the Hungarian Central Statistical Office, domestic expenditure on research and development has been rising for years, reaching an unprecedented HUF 702 billion in 2019, which is more than double of the 2010 expenditure. Medical sciences and health industry are traditionally outstanding in the Hungarian RDI landscape, but contributions from this sector are even more appreciated due to the coronavirus pandemic crisis. Government funding to foster research, development and innovation sees a significant increase also this year: over HUF 160 billion will be spent from national funds, while the new EU financed operational program will bring further calls worth several hundred billion HUF for the Hungarian RDI ecosystem, just in 2021 alone. - Dr. Zoltán Birkner (National Research, Development and Innovation Office)

keynote: Latest news of digital health development - By the development and nationwide introduction of the National eHealth Infrastructure, Hungary is leading the way in laying the foundation of a digital healthcare system. In terms of digital public services, this infrastructure is still one of Europe’s best. In November 2017, Hungary introduced an accessible and effective digital infrastructure that provides major developments for the domestic healthcare system. Digital solutions and telemedicine both have huge potential for our future society, as the structured collection, storage and lawful utilization of healthcare data represents a significant value. Today the National eHealth Infrastructure (EESZT), operated by the National Healthcare Service Center, is an integral part of healthcare and diagnostic work and is used by physicians and patients as well. - Bálint Szabó (National Healthcare Service Center)

Understanding the endless complexity of the human body and predicting its diseases - Medipredict is a digital health company providing a comprehensive evaluation of individual  health status by combining information from multiple sources, such as detailed medical examinations,  medical imaging, microbiome analysis, metabolomics, genomics and processing medical history. Our  mission is to help people maximize their health by using cutting-edge technology and evidence-based  science to predict disease risk, provide early detection and give actionable insights to maintain optimal  health. -  Richárd Kiss, MD, PhD (Medipredict)

New medical technology solutions in remote patient management - Diabetes mellitus is responsible for a huge burden of disease all over the world, including Hungary, as well. Diabetes is associated with an increased risk of numerous serious complications and comorbidities, although the risk is reduced if diabetes is well controlled. Diabetes imposes an increasing economic burden on each country healthcare system especially due to the treatment of complications. Remote monitoring is not the future any more. Remote monitoring is a clinically proven solution that improves therapy outcomes and follow-up efficiency, while not compromising on safety. - Zoltán Melicher and Csaba Varga, MD (Medtronic Hungary)

Digital development in Hungary’s health care and health industry: building a digital ecosystem. The role of digitalization: improvement and protection of public health care. What are some of the problems in public health care that can be solved by digitalization? What has been solved already and what still needs to be done? - Tibor Gulyás (Ministry of Innovation and Technology), Károly Hajzer (Ministry of the Interior), Prof. Ildikó Horváth, MD., PhD (Ministry of Human Capacities), Bálint Szabó (OKFŐ) - Moderator: Hatem Lemia (Novartis Hungary)

Cyber challenges in healthcare - András Kabai and László Tóth (Deloitte Cyber Risk Services)

Telemedicine with utilization of BigData: COVID applications  - The unique insights accessed through BigData are already utilized by healthcare professionals in several disease areas to optimize therapy efficiency and drug adherence. Since the beginning of the pandemic, the potential of telemedicine and BigData are increasingly recognised by decision makers. In times when doctor-patient interactions are limited, the value of monitoring patients' health status remotely via smart devices has significantly increased. How do you utilise a telemedicine infrastructure to gain insights on coronavirus while keeping you patients safe? - Fruzsina Mezei and Rudolf Mezei (Omron Medistance) 

Immersive VR/AR Aand Mobile Solutions in the Health Sector – DO’s and DONT’s with several use cases - Immersive and mobile technologies can be efficiently used in any field of any pharmaceutical companies or hospitals – if they really help the daily operation of the users and the organisation. Our lecture summarizes the practical requirements of several types of digital solutions throughout their development, introduction and daily use – presenting several good and bad examples and using our own IVFSIMPro project as a poster child - Szabolcs Budaházy (ARWorks) presentation

Digital, Channel & Tech Innovations In Times Of Change: Keep up with business-critical innovation and tech adoption trends. A Look Forward To 2021 & The Future Of Pharma: How has the face of pharma changed, is it embedded and what must we prepare for now? - Pharma Digital panel discussion - (MSD), Péter Vereckei, MD (Pfizer), (Richter Gedeon), Moderator: Zoltán Novák, Ph.D. (TaylorWessing)

Hungarian telemedicine trends in 2020 during COVID - Telemedicine allows health care professionals to evaluate, diagnose and treat patients at a distance using telecommunications technology. As part of the measure related to the epidemiological situation, Decree No 157 of 29 April 2020 was published in the Magyar Közlöny. One of the most important points of the Government Decree is that the personal presence of the patient is not a condition for the provision and financing of the health care service, if the nature of the healthcare and the medical judgment allow it. The use of telemedicine due to the situation became a daily practice for both GPs and specialists in Hungary, and this trend does not reverse. We initiated a representative research by interviewing 600 doctors from 15 specializations to explore their impressions, the pros and cons of telemedicine, and how it can improve the quality of patient care. - Balázs Kertész (Szinapszis)

University education in Health management - Round table with the professors - Balázs Benyó, PhD (Budapest University of Technology and Economics), Miklós Kozlovszky, PhD (Óbudai University), Mihályi Péter, PhD (Budapest Corvinus University), Miklós Szócska, PhD, MD (Semmelweis University) Moderátor:


Library (first floor)

A roundtable of Israeli digital health startups - Alon Kushnir (RedDress), Eyal Copitt (Cardiacsense), Jordan Rubinson (PulseNmore) - Moderator: Szabolcs Szolnoki (Science and Tech Diplomat of Hungary in Tel Aviv)

A roundtable of Hungarian digital health startups - Sándor Békási, MD (Fitpuli), Gábor Tóth, MD, PhD (Insimu), Moderator: Olivér Koppány, Esq. (KNP LAW)

Venture Capital in the health industry - Gergely Szűcs, PhD (Cashline Investments), Ernő Duda (Solvo) - Moderator: Zita Albert (Cerha Hempel)

Put Patients At The Heart Of Your Strategy: Easy-to-use platforms, action-driven strategies and customer-centric comms to boost patient engagement today - Pharma Digital panel discussion -  (Roche Hungary), Ákos Kókai-Nagy, MD (Biogen Hungary), Roland Kreissig, MD (Novartis Hungary) - Moderator: József Bulcsú Fenyvesi LL.M. (Oppenheim)

Digital Therapy Planning in Precision Oncology - Every patients’ tumor harbors an individual combination of 4-5 mutations out of 6 million potential mutations of 600 genes. There are already 100 targeted therapies in clinical use, and there are around 1000 in clinical development. The challenge of precision oncology is to choose which mutant gene to target with which targeted therapy to achieve response in the presence of the specific mutation and the presence of all the other mutant genes. The solution to this problem is the help of artificial intelligence. This new software that guides therapeutic decisions belongs to a new medical device class called „digital therapeutics .” Digital therapy planning can potentially increase the efficacy and cost-efficacy of precision oncology. - István Peták, MD, Ph.D. (Oncompass) 

Remote patient follow-up - Monitoring, illness detection and prevention, Capitalize on wearable technologies to continuously monitor and detect illness through real time patient-generated data analysis. Collaborate with industry counterparts including academic medical researchers, patient organizations and pharma - to lead research and pioneer approaches to cancer treatment, diabetology and more. Assess remote and centralized monitoring tools to ensure data quality, site support and patient safety - Péter Becságh, PhD. (Roche), Zoltán Melicher (Medtronic Hungary), Barnabás Szabó (77 Elektronika) - Moderator: Kornél Szabó (Sárhegyi Law Firm)

Benefits and challenges of remote patient follow up – a clinician’s view - Patients receiving a cardiac implantable electronic device –e .g pacemaker, defibrillator, event recorder – are an optimal target for remote follow up. The implanted device collects numerous valuable clinical data, which could be collected and monitored in a remote center. Remote monitoring in difference patient groups has been effective to prevent hospitalisation and prolong life. Nevertheless, the wider use of the technology is slowed down by several challenges. - Gábor Duray, MD (Honvéd Hospital)

Digital health solutions in the pandemic management - In our presentation we review the potential options for the control of the pandemic and how health data science, building on the methodology of Big Data and network research can help implement them. It is also important to note that the use of these modern technologies is of paramount importance not only in combating the pandemic but also in preparing for similar threats in the future. So certain data collections, database connections, and the creation of integrated large databases are not only intended to support prompt decision making with immediate results, but also to prevent the government from making decisions with such serious consequences during the event of a subsequent epidemic. - Miklós Szócska, MD, PhD (Semmelweis University Institute of Digital Health Sciences)


Workshop room (3rd floor)

Roche Workshop - Master of ceremonie: ................  (Roche Hungary)

Novartis Digital Health Startup Competition - 6X8 mins Startup Pitch, discussion with the jury, award ceremony- Juries: Otto Albrecht (Cashline Investments), (Hiventures), Krisztián Kölkedi (NKFIH), Tamás Rákóczi (Novartis Hungaria) 

Digitalization in the private clinics. - The consumerization of health and the importance of patient experience. As consumers increasingly shop around for healthcare, understand the importance of patient experience to protect your patient relationship. Address costly inefficiencies in the patient journey such as hospital throughput to get patients from the start to finish of their journey in the most expeditious and safest way possible to improve both cost and clinical quality. Seamlessly connect experience across channels (and across providers) to be more than just a ‘digital front door’, removing friction from patient pathways like scheduling and billing - Anna Balázs, MD (Déli Clinics)

eHealth literacy: can one have too much of a good thing? - Digitalisation transforms radically health systems and patient-doctor relationships worldwide. People have access to health information without limits, while the paternalistic patient-physician relationship is gradually moving towards a partnership. However, contents available on the internet are frequently inadequate, and can be even harmful. Patients are becoming increasingly responsible for appraising the reliability of information from the internet. From a large national survey we gain overview about the eHealth literacy of the Hungarian general population, and we get insights about its relationship with people’s health status, lifestyle and patient-reported experiences with healthcare. - Zsombor Zrubka, MD, PhD, (HECON-Health Economics Research Center, Óbuda University)

Healthsecurity challenges in the 21st century - Healthsecurity comes to mind most when we are suddenly threatened. Most of us don’t think that the safety of our health, the safety of our health protection and recovery systems, is threatened by global trends. In our presentation, we discuss healthsecurity and healthsecurity issues along a broader system of aspects. We present the healthsecurity aspects of health status, vaccinations and anti-vaccination activism, and data-driven health- and cybersecurity. - Tamás Palicz, PhD, MD (SE, EMK, Deputy Strategic Director)


Networking room (2nd floor)

Coffee, sandwich, networking, meeting room

Partner, CERHA HEMPEL Dezső & Partners Law Firm

Zita is M&A partner of CERHA HEMPEL Dezső & Partners Law Firm, with over 16 years of experience in m&a transactions. She has extensive experience in advising on complex domestic and cross border M&A transactions in a wide range of business sectors, including health care. She has led a number of transactions in the health care sector in the past years representing either joint ventures, private equity firms or international healthcare providers.

market development and strategy planning, Roche Hungary

We in a Healthcare Innovation team work together to identify and incubate ideas around personalised Health Care concepts.  Originally I graduated as a Biotechnologist and I did my PhD from Molecular Pathology. I had a possibility to join for some years to a research group in Austria and also in Germany to study the molecular background of Atherosclerotic lesions. 




Chief Product Officer

Dr. Sándor Békási graduated from Semmelweis University (Budapest, Hungary) as a primary care physician and health manager. After graduation, he was involved in molecular biology research activities, and later, his attention turned to client-centric digital health care solutions and primary care. He is the co-founder and Chief Product Officer of Fitpuli, a Hungarian digital health startup, and chief physician at the Health Center of the Hungarian Charity Service of the Order of Malta. Additionally, he is a member of the advisory board of multiple Hungarian and international digital health startups and an external expert of the European Commission. His main interest is the integration of mobile applications, telemedicine, and remote patient monitoring into traditional medical care pathways.

Professor at the Department of Control Engineering and Information Technology
Budapest University of Technology and Economics

Prof. Benyó received his Ph.D. degree from BME in 1998 and Dr. habil in 2013. He received Candidate of Science degree from the Hungarian Academy of Sciences in 1998. Between 1998 and 2008 Prof. Benyó was working at the Department of Informatics, Széchenyi István University, Győr where he was the Vice Dean of International and Scientific Affairs and Secretary of the Multidisciplinary Doctoral School of Faculty of Engineering Sciences between 2005 and 2006. Prof Benyó's Selected Major Honours, Awards, Invited Positions and Fellowships: Adjunct Professor/Adjunct Associate Professor (Reader) University of Canterbury, Department of Mechanical Engineering, Christchurch, NZ (2020 / 2013);  Eötvös Fellow (by State of Hungary, 2007);  “Outstanding creator of the year” (For Technical Development of the Industry Found, 2002); Békésy György Post-doctoral Fellow (by Hungarian Academy of Sciences, 2001); Bolyai János Research Fellow (by Hungarian Academy of Sciences, 1998); Soros Short Fellow (Soros Foundation, 1993); Invited Guest Editor of three Special Issues of biomedical engineering journals (Journal of Biological Signal Processing and Control, Control Engineering Practice); Co-Chair of International Federation on Automatic Control (IFAC) Technical Committee 8.2 Biological and Medical Systems. His research interest includes, among others, the modelling and control of physiological systems, model based medical diagnostic and treatment solutions, metabolic control; Nuclear medical imaging, image reconstruction algorithms, parallel implementation of SPECT reconstruction in GPGPU platform; Medical image processing, fuzzy methods, image based medical diagnostics, medical informatics; Mobile and contactless technologies (including Near Field Communication Technology) to create novel technological solutions and services, system security, safety critical solutions. Prof Benyó is the leader of the Biomedical Engineering Laboratory at the Department of Control Engineering and Information Technology working in theoretical and applied research in biomedical engineering and medical informatics for 15+ years. The Laboratory provides the basic infrastructure for Biomedical Engineering training at the Faculty of Electrical Engineering and Informatics. Prof Benyo is the leader and/or participant of several successful OTKA (Hungarian Scientific Research Fund), EU financed national (GVOP) and international (Copernicus, FP6, FP7, H2020) projects, and is coordinator of the DCPM: Digital Clone for Personalized Medicine (EU H2020-MSCA-RISE-2018 call, Grant ID: 872488). Prof. Balázs Benyó has published more than 350 scientific publications, received more than 1800 references, his h-index is 21.

President of the National Research, Development and Innovation Office

His professional career demonstrates thorough experience in higher education as a lecturer and education organiser, in scientific life as a researcher of innovation management, and in the business sector as a manager dealing with organisational and business development and industrial research and development projects.

founder and CEO

Szabolcs Budahazy is the founder and CEO of ARworks, the AR/VR and mobile app developer company serving clients since 2010. ARworks’ team of 50 is a the leader of the Hungarian Virtual and Augmented Reality development market and among others have long experience in health and pharma related solutions. Besides the local market, ARworks has a strong presence in other foreign markets as well – like the UAE or Kuwait.

One of their biggest clients is Novartis’ HQ in Basel but they developed  projects for several other pharma companies as well. Among others there is a symptom tracker app for patients, a training app for nurses on the preparation of a drug, or an app helping patients and their families coping with a certain disease. 

VR technology gaining more and more ground in trainings. A good example for this is IVFSimPro, ARworks’ in-vitro fertilisation training simulator. The solution is launched during the Summer 2021 and helps professionals to learn the IVF process using either a VR headset or a simple browser based solution running on their laptop.

Chief Commercial Officer
Cardiacsense, Izrael

Over the past 20 years, Eyal Copitt’s professional experience has focused on international business and technology covering multiple disciplines, including satellites, data storage, bandwidth optimization and in the last years in pharma and medical devices. His management success is a function of his sharp analytical skills, long-term vision, and expertise in Go-to-Market strategy planning.

Solvo Biotechnology

He is a serial entrepreneur and investor, he has founded or co-founded over two dozen companies. He’s the founder and CEO of Solvo Biotechnology, the largest biotech company in Hungary. He is the founder and president of the Hungarian Biotech Association and of Medipredict, a company in the personalized health prevention and prediction field. He is an investor in 20+ startups and focuses on early stage companies in the areas of life sciences/medtech/AI/blockchain. He is an associate professor at the University of Szeged since 2003, where he teaches Biotechnology and Entrepreneurship and he also gives lectures at the Aquincum Institute of Technology. He is the founder of a school in Szeged, called Szikra. Szikra is a practical and experience-centered nonprofit institution, its goal is to become a world class primary and secondary school.

vezető főorvos, Kardiológiai osztály, Elektrofiziológiai és Pacemaker részleg
Magyar Honvédség Egészségügyi Központ 

Belgyógyász – Kardiológus, nemzetközileg jegyzett szívritmuszavar specialista. Általános orvosi diplomáját a Semmelweis Egyetemen szerezte, majd a szakképzése után 2005 és 2010 között a Frankfurti Egyetem Kardiológiai Klinikáján dolgozott, ahol a szívritmuszavar részleg főorvosaként dolgozott. Európai Kardiológus diplomát szerzett, majd az Európai Kardiológus Társaság tiszteletbeli tagjának választotta. A Semmelweis Egyetemen szerezte PhD doktori (2009) címét, Egészségügyi Menedzser MSc diplomáját (2019), majd ugyanitt habilitált (2020). A Magyar Kardiológusok Társasága Aritmia és Pacemaker munkacsoport alelnöke. Kutatási érdeklődési köre a szívritmuszavar, valamint szívelégtelenség miatt eszközös kezelésre szoruló betegek ellátási módszerei, a katéteres, műtéti (pacemaker, defibrillátor), valamint gyógyszeres kezelési stratégiái. Bevezette Magyarországra a legmodernebb, teljesen a szívbe ültethető törpe pacemaker (Micra) alkalmazását, és tapasztalataival nagymértékben hozzájárult a technológia széleskörű elterjesztéséhez. A mindennapi betegellátás mellett fontos számára az eszköz- és gyógyszergyártókkal való szoros együttműködés, a diagnosztikus és terápiás eljárások kifejlesztésével és alkalmazásával kapcsolatos kutatómunka.

Graduated from the Janus Pannonius University of Pécs in 1998 and pursued postgraduate studies in EU law at the University of Pécs. Obtained an LLM in International Economic Law at the University of Warwick in 2004. Attended the University of Oxford as a Chevening scholar and received a Magister Juris degree in 2006. Joined the Budapest office of Freshfields Bruckhaus Deringer in 2005. Associate of Oppenheim since 2007, partner at the firm since 2010. Head of the Corporate practice of Oppenheim since 2014.
Areas of specialization: Company Law, M&A, Capital MarketTransactions.
Sector experience: Capital markets, Chemicals & Pharma
Languages: Hungarian and English

Deputy State Secretary
Innovation of the Ministry of Innovation and Technology

As the Deputy State Secretary for Innovation of the Ministry of Innovation and Technology, I am responsible for the development of the Hungarian innovation ecosystem. I carry out this mission with the conviction that the knowledge base of Hungarian researchers and the talent of the next generation provides an indispensable opportunity for Hungary. The efficient use of these resources must be increased for the success of society and the economy. The recent period has proven that our work vitalizes and strengthens the organizations and other actors of the R&D and innovation field.

In my entire life, I pay undivided attention to the analysis of social, political, and economic trends.

Deputy State Secretariat
Ministry of Interior 

He was born in 1957. He was graduated at the College of Nyíregyháza as a plant engineer, then at the University of Agricultural Sciences in Gödöllő, as a mechanical engineer. He acquired a degree as a police officer at the Police College in 1985 and as a specialist engineer in IT at the University of Gödöllő in 1995. He worked as a detective and a forensics officer, and later as a head of unit, in the Police Headquarters of Szabolcs-Szatmár-Bereg County between 1981 and 2003. Afterwards, until 2010, he worked as a head of the Unit for System Development at the National Police Headquarters. He became the head of the Department of Informatics in the Ministry of Interior in 2010; from 2014 he is responsible for the supervision and coordination of this field as a deputy state secretary. As a ministerial commissioner, between 1999 and 2002 he was responsible for the nationwide implementation and managing the development of the base information system of the Police, while between 2011 and 2014 he was responsible for managing the planning and the initial implementation of the Single Emergency Call System and organising the activities related to the 2 development, deployment, and extension of the Robotzsaru case management system, as well as supervising their implementation. As the Deputy State Secretariat for Informatics in the Ministry of Interior, he has been responsible for creating several important e-Government services, like the Central Receipt System (KÉR), the e-Paper service, and the Company Gate service, alongside with the development of other facilities enhancing the security and performance of systems, like the Government Data Centre (KAK) and the Government Data Vault (KAT).

Team leaders
Deloitte Hungary │ Cyber Risk Services

Andras is a Director in Deloitte Cyber Risk Services team with over 18 years of experience in IT security. András is recognized as an international expert in penetration testing, exploiting and assessment. He has strong automotive security testing experience with connected vehicles, automotive specific buses and components.

He is the designer and lecturer of custom car hacking and hardware hacking training programs (including custom electronics, PCBs, simulated ECUs) made for different Automotive OEMs and other clients. Andras established and leading Deloitte Hungary’s hardware hacking service line and he is also responsible for the cyber practice’s IoT and car hacking services. He and his team delivered hardware hacking projects worldwide and have clients from Automotive, IoT and FSI sector.

Prior to joining Deloitte Andras was the lead IT security expert at CERT-Hungary / National Cybersecurity Center and participating in several penetration tests and other IT security projects.

Andras is a regular lecturer and presenter on IT security conferences and professional events.

He holds various industry recognized certificates: OSCP, OSCE, OSEE, GPEN, GWAPT, GREM, GXPN, CEH

Innovation and Managing Director, Consultant, Owner

Balázs has an MA in Economics and works for Szinapszis from the beginning as the professional leader of researches, also responsible for internal innovation and international relationships.  Balázs is a developer Szinapszis’ branded pharmaceutical solutions and research models. Main research areas: sales force effectiveness, pharmaceutical targeting, segmentation, KOL mapping, price sensitivity tests, MCM and digital transition in the pharma industry. Presenter on various Hungarian and International conferences, member end representative of Szinapszis in the European market research associations (ESOMAR, EphMRA).

Medical team leader

Dr. Richard Kiss earned his medical degree from Semmelweis University, after which he  obtained a PhD degree from the MTA-SE Momentum Molecular Oncohematology Research Group.  His research topic was the mapping of the genetic and epigenetic background of leukemias and lymphomas, during which he gained extensive experience in the application of molecular genetic  methods to support the personalized treatment of hematological malignancies. During his studies, he  gained professional experience in Taiwan, Germany and the Netherlands, and is a frequent speaker at  Hungarian scientific conferences as well as at patient education and scientific events. As the leader of  Medipredict’s medical team, he works to integrate the results of state-of-the-art medical testing with  omic studies to identify individual disease risks and develop personalized intervention options.

Country Director
Biogen Hungary

Dr. Ákos Kókai-Nagy is currently the Country Director of the Hungarian Affiliate of Biogen

pharmaceutical company since 2017. Also, he is a Board member of the Association of Innovative Pharmaceutical Manufacturers (AIPM) since 2017, and the elected President of the organization since

2020. Dr. Ákos Kókai-Nagy graduated from Semmelweis University and, after several further courses, he graduated in 2012 with an EMBA qualification from Purdue University International Master of Management. During his career, he has held management positions at several pharmaceutical companies both in Hungary and abroad, including since 2012 he has been the Managing Director of Astellas Pharma in Denmark.

Head of the RDI Services Department, National Research, Development and Innovation Office

After dealing with own startups he got involved in business development, then carried on as an organization development coach and top management adviser. Currently he is engaged in launching innovation services for the Hungarian ecosystem, which includes a mission to boost youth and startup programs. Created with his supervision, the Hungarian Startup University Program now plays a key role in promoting entrepreneurship and innovative mindset among Hungarian university students.

Attorney at Law, Foreign Legal Counsel

Olivér Koppány is a lawyer who’s main focus is on issues involving cross-border pharmaceutical transactions, start-up’s legal matters, international commercial contracts and matters that concern the United States and Hungary. He is admitted to the District of Columbia (Washington DC) Bar and the Budapest Bar Association as a Foreign Legal Councel. KNP LAW’s main profile is Pharmaceutical & Life Sciences Law, including competition law issues, regulatory and pharma-marketing matters. They regularly represent and advice pharmaceutical companies, health care providers, and other key players in the pharma industry.

Óbuda University (Hungary)

Dr. Miklos KOZLOVSZKY is a full Professor at Óbuda University (Hungary), head of the BioTech Research Center (BTRC) and the John von Neumann Faculty of Informatics, besides that he is working as Senior Research Fellow at the Laboratory of Parallel and Distributed Systems in the Computer and Automation Research Institute of the Hungarian Academy of Sciences. He is full professor (since 2020) and received his habilitation (in 2017) at Óbuda University. He received his PhD from the Budapest University of Technology and Economics (Hungary) in 2009, and his MSc in Computer Science from the University of Szeged (Hungary) in 2001. He is a lecturer at various Universities: at Óbuda University (Hungary) since 2005, at Semmelweis University (Hungary) since 2015 and at National University of the Litoral (Santa Fe, Argentina) since 2017. Before that, he was working: as researcher in the Bioinformatics Group at IMP /Research Institute of Molecular Pathology/ (Austria), at CERN /European Organization for Nuclear Research/ (Switzerland), and as team leader at Vodafone Hungary (Hungary). During last 20 years he was involved in many EU FP6, FP7 (SHIWA, HP-SEE, SEE-GRID-SCI, EGEE, EGI, …) and H2020 projects at various positions (deputy project leader, WP leader, engineer, etc.). He is author and co-author of 180+ research articles in peer-reviewed journals and books.

general manager
Novartis Hungary

He is currently a General Manager for Novartis Oncology responsible for a cluster of 15 countries in Central Eastern Europe. Roland is a physician by background but switched his career from academic medicine to working as a consultant at McKinsey before joining Novartis in 2004. At Novartis, Roland has been working in various leadership roles across geographies, in the US, in Europe, and in Global roles, and across different functions with a focus in Marketing, Sales, Strategy, and General Management.

CEO & Founder of RedDress ltd.

Entrepreneur and founder of several successful medical device startups for the past 22 years. He is the founder and CEO of RedDress ltd, leading it from an idea a to successful commercialization around the world. Earned two BAs with honor in computer science and life science from Bar Ilan university, Israel. He led the design and conduct of over 60 clinical studies in North America, Asia, Europe and Africa and has 16 medical patents in various fields, including pulmonology, cardiology, interventional cardiology, urology, dermatology and Gynecology. 

Head of Public Affairs, Communications
Novartis Hungary

Lemia is an economist, graduated from Corvinus University of Budapest. After a short time spent in FMCG (Unilever) she immediately jumped into the world of pharmaceuticals where she’s been since 11 years now. After several roles in Communications and Public Affairs at Sanofi where she also spent a year in Sofia, Bulgaria; she joined MSD as Policy and Communications Lead where she was heavily involved in shaping public discussions around HPV vaccination and lung cancer. She is currently heading Public Affairs, Communications and Advocacy at Novartis Hungary. Lemia is passionate about public health issues, especially addressing health literacy & education and she’s a strong believer in the change civil society and patient advocates could make.

Health Policy Expert & Health Economist

As a Health Policy Expert of the Hungarian National Public Health Centre since 2017, Fruzsi is strategically planning and implementing evidence-based developments in the field of primary care. She is currently working on improving care of six chronic disease groups that are leading causes of death in Hungary (e.g. hypertension, diabetes, oncological diseases etc.). She graduated as a Medical Anthropologist from Durham University in 2017 and received her MSc in Health Policy, Planning and Financing from ELTE in 2019. Stemming from her research background, she is an advocate of evidence-based policy making and aims to disseminate the idea of data collection and analytics to systematically address leading health issues. Working on national and international health care projects, primarily in the field of chronic care, she has first-hand experience in the barriers of implementing innovative digital solutions in the public health sphere. She works to overcome these barriers.

CEO, Owner of OMRON-Hungimpex Ltd. 

Since 1991 he has been leading the Hungarian brand representation, sales and development center of the Japanese-based OMRON Healthcare Division. For nearly three decades, he has conducted and implemented prevention, research and development programs that determine the qualitative hypertension, health, and chronic disease prevention, making digital blood pressure monitoring and international practice based on it accessible to everyone at home, as well as providing the education of same. In 2010, he developed, tested and marketed the first service product category, value chain, and partner network to create large data assets related to digitalized health status, which product is recently entering the market abroad, in strategic cooperation with foreign and domestic partners. He was the first to launch a health monitoring service based on the quality-assured, certified, IoT connected device structure and digital medicine data processing method for domestic health care providers and pharmaceutical industry stakeholders. He graduated in 1983 from the College of Foreign Trade and later in 2012 got degree in economics, specialized in healthcare management from Corvinus University. Together with his colleagues, he became committed to the strategic planning, research and modeling of the future of domestic health prevention, resources and predictive setups in domestic and international projects, expert’s and IT professional programs, and received his qualification in this field at Eötvös Loránd University Health Politics MSc. degree in 2019. Under his leadership, several domestic and foreign programs are underway to systematize digitized markers of chronic illness health conditions, organize them into big data assets, data mining, as well as develop related artificial intelligent algorithm systems, predictive analytical modeling of health status data, and integration into business applications via standard platform. As a publisher of numerous lectures, articles and on-line entries, he aims to modernize domestic health prevention based on digitalized data, to prepare the decision-makers, medical professionals, and the public to appreciate, receive and use digital data-based healthcare.

economist, professor at Budapest Corvinus University

He started his academic career after graduation from the Karl Marx University of Economic Sciences in Budapest. Between 1983-1993, he was a researcher of the UN Economic Commission for Europe in Geneva. After returning to his native country, he became an active participant of the Hungarian privatization process. He served – inter alia – as Deputy Government Commissioner for Privatization in 1994/95 and played a major role in the largest transactions in energy and banking. In 1997/98 he was promoted to Deputy State Secretary in the Ministry of Finance. His portfolio included the pension reform, the preparation of the healthcare reform and municipal financing.

Professor Mihályi has more than two decades of experience in teaching health economics at BA, MA and PhD levels. Since 2012, he is Editor-in-Chief of Acta Oeconomica, an English language academic quarterly with an impact factor (2019: 0.914).

During the last 15 years, Professor Mihályi's research has been focused on health policy issues. He is currently affiliated with the Corvinus University of Budapest as tenured professor of the Economics Department and the Central European University as a Recurrent Visiting Professor since 1996. Professor Mihályi is an often consulted expert by UNCTAD, UN ECE, the World Bank and the European Union. He authored 12 books, from which five dealt with healthcare. His most recent English-language book is entitled, Health Insurance Reform in Hungary, Vol.1-2. In 2006-2008, he was the Personal Advisor of two successive health ministers in Hungary. Simultaneously, he was Leader of the Health Committee within the State Reform Committee. During the recent COVID-19 crisis, Professor Mihályi published several articles in the Hungarian press in order to inform the public about the most recent scientific findings.



founder, Digital Health Summit

Rita Molnar earned her BA business communication degree in the Budapest College of Communication and Business in 2008. She completed her MBA master program at Budapest Metropolitan University in 2020 and she is now pursuing a Health Policy, Planning and Financing Master’s program at Budapest Corvinus University. The program is designed to provide you with a comprehensive understanding of the complexities of health care systems both at macro- and micro-levels within the context of technological development, an ageing population and patient expectations. She will be well-prepared to work in health administration, government departments, research and consultancy agencies, universities, national health services, health care organizations and pharmaceutical and medical device industry. 

She started her career as a professional photojournalist from 1997 to 2002. Rita was just 21 when she started organizing events, and she founded her own company. Her first event was an amateur film festival in Eger in 1998. Ever since, she has been organizing 2 conferences per year, mainly in the medical, VC investing and banking fields. Between 2001-2005 Rita also worked as a movie producer. She was involved in co-producing a movie directed by the iconic Magyar movie-maker Miklós Jancsó. From 2006 to late 2007 Rita managed the event marketing team at Ringier Publishing, a Hungarian subsidiary of a Swiss-based leading publishing firm. In the summer of 2010 Rita founded Slimexpo with a venture capital involvement, and she organized with her own team a Slimexpo Festival with a diet, health and beauty theme at a premium event venue in Budapest Aréna in the spring of 2011. 


Zoltán obtained his law degree in 2009 from the University of Debrecen. He also studied in Tübingen, Leuven and Amsterdam. He holds an LL.M in International Dispute Resolution from Queen Mary University in London and defended his PhD in 2011. In 2014, he successfully passed the bar exam.

He acquired his first professional experiences in the German Federal Parliament. In 2010 he started his career as a lawyer. Since 2018, he has been a partner at Taylor Wessing Budapest.

He specializes in pharmaceutical law, intellectual property law and dispute resolution and regularly provides legal advice to international pharmaceutical and tech companies on corporate, marketing authorization, intellectual property and labour law matters. In addition, he has extensive international litigation and arbitration experience.

Zoltán is the author of several publications. His academic articles have appeared in the journal “Gazdaság és Jog”, the Oxford Journal of Intellectual Property Law & Practice and the Kluwer Arbitration Blog, among others.

In 2018, he and his colleagues won the Wolters Kluwer Lawyers’ Award in the category of intellectual property law.

managing associate
Andrékó Ferenczi Kinstellar Ügyvédi Iroda

Zsombor Orbán is Managing Associate in Budapest and head of the Hungarian TMT practice. He focuses on data protection and data privacy, technology, media & telecommunications and intellectual property law. He oversees and coordinates all privacy work in the Budapest office and is responsible for privacy matters in the cross-office TMT team. Zsombor actively participates in public conferences as a speaker; he also holds trainings for clients, and is frequently invited to participate in privacy-related legislation work for the Ministry of Justice. With his extensive industry knowledge and his in-house experience, Zsombor is an expert of the TMT sector, representing the clients in regulatory and transactional matters, commercial and technical issues, data protection, digital media, competition and trademark law, and also in infringement proceedings. He also has extensive experience in traditional intellectual property cases including - amongst others - registration and filing, trademark litigation, domain disputes, preliminary injunctions, trademark portfolio management, planning filing strategies, assisting marketing in intellectual property cases, know-how and business secret protection, and patent litigation.

He is recognized by the 2021 edition of Legal 500 as a ‘Next Generation Partner’.

He graduated from the University of Pécs, Faculty of Law. He is member of the Budapest Bar Association. He speaks Hungarian and English.

strategic deputy director, Semmelweis University, Health Services Management Training Centre

Dr. Tamás Palicz obtained his doctoral degree in medicine at the University of Debrecen in 1993, then in 1998 he became a specialist in internal medicine at the 3rd Department of Medicine of Semmelweis University. After several years of clinical practice he started to plan, implement and monitor EU-funded projects. He has been working as a manager since 2003, initially as Deputy Director General of the Directorate General for Strategy and Operational Development at Semmelweis University, and from 2005 as Medical Director of the Kútvölgy Clinic. Between 2010 and 2013, he was the Head of the Managing Authority for Human Resources Development and Renewal Operational Programs (TIOP and TÁMOP) of the National Development Agency, which was responsible for planning and monitoring the implementation of these projects. From 2013, he worked for two years as the Deputy Director General of the National Institute for Health Development and as the professional leader of the TÁMOP-612A-14/1-A project, where he was responsible for the introduction of school health promotion. Since the end of 2015, he is the Deputy Strategic Director at the Health Services Management Training Centre of Semmelweis University, where he earned his Masters's degree in Healthcare Management in 2001. 

His main areas of interest are process-oriented management of healthcare organisations, leading organisational changes and project management in healthcare. In recent years, in the context of the digital transformation of healthcare, he has begun to address cybersecurity issues within healthcare organisations.

CEO, Oncompass Medicine

Istvan Petak, MD, Ph.D., is a physician and researcher. He has been developing technologies together with his team to find the best personalized, targeted therapy for cancer patients for over 20 years. His group was one of the pioneers of predictive molecular diagnostics. Their current development is a method to match the best, targeted therapy to each genetic alterations or combination of genetic changes in every cancer patient. This technique is being implemented into an artificial intelligence-based medical software system. This system and method received the award of the American  Society Clinical Oncology at their Breakthrough Oncology conference in Bangkok, and it also won the innovation prize of the GET IN THE RING V4, in 2019. Dr. Petak is the founder and CEO of Oncompass Medicine and regular lecturer of the Semmelweis University, Budapest, and the University of Illinois at Chicago.

Digital Lead
Novartis Hungaria

Tamás graduated as an economist and began his pharmaceutical career at Pfizer in 2009. During his more than 10 years there, he gained extensive experience in various departments (Finance, Business operation, Global Commercial operation), which was later utilized in the field of sales force excellence and he also played a decisive role in the company's digital development and implementation of new systems. After nearly 10 years on the support side, he had the opportunity to prove his abilities on the business side, for a year and a half in the Internal Medicine business unit he was responsible for promoting selected products through digital channels. He joined Novartis’s cardiovascular business unit as a product manager in 2020 and will continue his career in the Digital Lead position from 2021, where his main responsibilities will be the company’s digital development, mapping and implementing new, innovative opportunities and transforming the Omnichannel approach theory into practice.

medical doctor, health care manager

Balazs has been graduated at the Semmelweis Medical School in 1992, then he got a further MSc degree at the London School of Hygiene and Tropical Medicine & London School of Economics and Political Science,  Public Health and Policy Health Care Management,  where he has continued his further studies at the Health Services Research Unit. Furthermore he has also graduated at the Eötvös Lóránd Science University Faculty of Social Sciences Health Economics Task Force on Drug Policy and Pharmaceutical Economics. His work experience encompasses wide range of health care sector: He has served as a General Practitioner, managing a public health institution, worked at the Ministry of Health, World Bank Public health programs, and also used to be director at the Pharmaceutical sector, as well as Private Health Insurance, Health Fund. He is proud to be the founder of the first Hungarian private health insurance providing in-kind care, or establishing health fund, and also he has participated in the foundation of the first Hungarian Fund Holding primary care model. With his 12 colleagues he is managing a medical devices distributor firm, besides he is providing health economics, health care management, health policy advices to several health insurance companies, health care providers. He is also the health policy advisor of the Major of Budapest. 

Chief commercial officer
PulsenMore, Israel

Jordan Rubinson has more than 20 years of experience in the pharmaceutical industry with large pharma companies like Pfizer, GlaxoSmithKline, and Aventis. He recently worked in early stage companies as a CEO of Regenera Pharma, as a Chief Commercial Officer for Champions Oncology, and was also the CEO of Polyheal Ltd, which was sold to TEVA at a $90M valuation. He worked at Pfizer as the marketing director for Israel, at GSK in U.S. marketing, and at GSK France, managing a large field force division of over 100 employees. While at Aventis, Jordan had assignments in France, Canada and the U.S. He holds an engineering degree from Columbia University and an MBA from MIT.

Head of EESZT Division at National Healthcare Service Center (ÁEEK)

Bálint Szabó is head of division at the National Healthcare Service Center (ÁEEK). He graduated at Eötvös Lóránd University, Budapest Technology University and Kossuth Lajos University. 

He is responsible for the establishment and operation of the National eHealth Infrastructure (EESZT), As the leader of the program aimed at establishing the future of e-health, he led the development of the EESZT, and now he leading its ongoing operation. This is solidly based on his professional background that includes experience in software development project management in various industries, as well as enterprise IT operation management. He regularly presents at IT conferences and he is the author of several professional publications.

deputy director of the Development Department, 77 Elektronika Kft

Barnabás is an engineer-economist with extensive experience in the medical device and diagnostics field.
He graduated from the Budapest University of Technology as a mechanical engineer in 2003 and did his postgraduate studies at the Budapest Corvinus University.
He started his career at the Budapest University of Technology, where he was involved in an international cardiovascular stent research and development project.
In 2007 he began to work at MED-EL GmbH. in Austria as a development project lead in the implantable neurostimulation field.
In 2011 he joined the Hungarian In Vitro Diagnostic company 77 Elektronika Kft. as diabetes topic manager and became soon deputy director of the Development Department. His responsibility is cross-functional device development of multiple product lines from idea to market release in international environment, including quality and regulatory aspects. His main area is Point of Care Testing and related digital health technologies.
Barnabás is a strategic planner with a high focus on medical product related innovation.
He is married and father of 3 children.

director, Institute of Digital Health Sciences
Semmelweis University

Miklós Szócska, MD graduated at the Semmelweis University (SU) of Medicine in 1989. He holds a Master of Public Administration degree from the John F. Kennedy School of Government at Harvard University (1998), and a Ph.D. from the SU in the field of change management (2003). After his graduation at the SU he and his colleagues initiated the creation of the Health Services Management Training Centre (officially established in 1995). Between 1995 and 2000 he was serving as the deputy director and in 2000 he was appointed to be the director of the Centre. Between 2010-2014 Dr. Szócska served as the Minister of State for Health of the Hungarian Government. Since 2014 he serves again as the Director of HSMTC and became responsible for the Institute of Digital Health Sciences at SU. In 2016 He was nominated by the Hungarian Government for the DG position of the WHO. In July 2019 Dr Szócska was appointed to be the Dean of the Faculty of Health and Public Services at Semmelweis University.

Science and Tech Diplomat of Hungary in Tel Aviv

Adapting to the characteristics of the Israeli ecosystem as the Science and Technology
Attaché of Hungary in Tel-Aviv he focuses on projects of applied research, experimental
development and startup cooperation. One of the flagship frameworks supporting the joint
RDI activities is the Hungary-Israel call for proposals in industrial research and development
published on annual basis. As a priority taks Mr. Szolnoki assists the interested companies in
searching partners. The areas of cooperation and interest mainly are: life sciences, digital
health, cybersecurity, mobility and autonomous vehicles, space-industry. Szabolcs Szolnoki is
a doctoral student at the University of Pécs, Insititute of Geography and Earth Sciences.
Before his diplomatic service he assisted innovative Hungarian inventors in starting their
businesses and entering domestic and foreign markets.

Member of the Board, Cashline Investments and CEO, Valor Capital

He graduated at the Budapest University of Economic Sciences and Public Administration as a financial investment analyst and risk manager in 2003. He has more than 12-years experience in venture capital and private equity investments, as well as, strategic and financial management of companies. Between 2003 and 2007 he worked for the Hungarian Development Bank (MFB) and MFB Invest Zrt. His position was investment analyst, he was responsible for the analysis of development plans, company valuation, the support of the operation of the portfolio companies, and the exit from the investments. He is working for Cashline Group since 2007 as a portfolio-manager, active in the deal flow generation, project analysis, valuation, management of the entire investment and exit process, as well as, strategic management of the portfolio companies. Since 2012 he is responsible for the venture capital activity of Cashline Group, and is the CEO of Valor Capital. He completed a Ph.D. Program at Corvinus University of Budapest, on the Department of Environmental Sciences and Technology in 2015. His research topics are environmental innovations and patents. He is managing director and board member of numerous Hungarian small and medium-sized enterprises.

senior associate
Andrékó Ferenczi Kinstellar Ügyvédi Iroda

Eszter Takácsi-Nagy is Senior Associate in the Life Sciences & Healthcare practice in Budapest. Her expertise includes in-depth knowledge of the pharmaceutical, biotechnological, healthcare and medical devices sectors and the related regulatory environment. Eszter also regularly advises on competition and state aid matters, and has leveraged that experience to deliver a broader and deeper service offering to the firm’s life sciences clients. Her client base includes national and international clients in respect of which she has advised on licensing, compliance, enforcement as well as sector related M&A.

Eszter was named Regulatory Rising Star at the LMG European Life Sciences Awards in 2020 and 2021. 

She graduated from Pázmány Péter Catholic University, Faculty of Law.  She is member of the Budapest Bar Association. She speaks Hungarian, English and German.


Gabor Toth, M.D., Ph.D. graduated as a medical doctor at the University of Debrecen with the highest honors in 2013. He was awarded the Pro Scientia Gold medal for his outstanding student research work. As the president of the Hungarian Medical Students' International Relations Committee, he was working on improving the medical education of Hungarian students. During his Ph.D. studies, his academic research was focusing on targeted cancer immunotherapies. In a bid to reform clinical education with standardized solutions, he co-founded InSimu Ltd in 2016. As the CEO and medical director of InSimu, he provides medical students, schools and professionals worldwide with an efficient practicing and assessment tool for clinical reasoning skills.

Team leaders
Deloitte Hungary │ Cyber Risk Services

László is a Partner in Deloitte’s Cyber Risk Services group. He has over 19 years IT security consulting experience. He performed and lead numerous IT security penetration tests and security reviews in highly sensitive areas including automotive industry, financial services, telecommunication and public sector clients.

His expert areas are various penetration testing services and incident response. He is a specialist in automotive security and has deep knowledge about a wide range of operating systems, databases, application frameworks and automotive technologies.

László has published his unique research results regarding Oracle database security and he is the developer of woraauthbf, which was the fastest Oracle password cracker at time of the publishing.

László also published his research on Android mobile forensic and encryption.

medical doctor, Business Manager
Medtronic Hungary

He spent 4 years as trauma surgeon at Petz Aladár County Hospital in Győr. Since 1994 he is working in pharmaceuticals and medical device market in different positions, mainly with sales responsibilities. He joined Medtronic at 2011 as Business Manager lead the Diabetes Business Unit, which provides medical devices and technologies for diabetes management including insulin pump and continuous glucose monitoring. Medtronic plays key role in the innovation of diabetes management with products and technologies which priovides both effective diabetes management and improved quality of life. Telemedicine is part of its portfolio.



managing director
Pfizer Ltd

Péter Vereckei, MD, graduated from the University of Medicine in Debrecen in 2000 and later continued his education in the field of health economics and health policy at Eötvös Loránd University. After graduating, he began a 20-year career in the pharmaceutical industry working for the Hungarian subsidiary of Pfizer, starting as a Pharmaceutical Sales Rep before taking an executive position in January 2014. From 2016, he has been a member of the board of Innovative Pharmaceutical Manufacturers, and from 2018 to February 2020, he was the president of the association. An important milestone in his professional career was the establishment of the National Pharmaceutical Identification Organization, implemented with the full cooperation of the pharmaceutical industry, in which he actively participated and was a member of the organization's board.

University Research, Innovation and Service Center, Óbuda University

In addition to his research in digital health, biotechnology and health economic evaluation, he is a lecturer of health economics and healthcare innovation for Hungarian and international students. Prior to his academic career, Zsombor has worked in child psychiatry, and then he spent 17 years in the pharmaceutical industry in various national and international roles including sales, medical, marketing and business unit management. He has worked in the European Brand Team of Pfizer from Hungary, Germany, the UK and France. At Egis Pharmaceuticals Plc. he led the launch of the first biosimilar monoclonal antibody in a number of countries in Eastern Europe and the CIS region. He graduated as a medical doctor at the Semmelweis University, and holds and MBA from the Oxford Brookes University as well as a PhD from the Corvinus University of Budapest.

Budapest Music Center

1093 Budapest, Mátyás street 8.